Published in J Surg Oncol on December 01, 1995
A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc Med (2011) 0.87
Multimodality therapy for malignant pleural mesothelioma. Ann Cardiothorac Surg (2012) 0.75
Antineoplastic activity of povidone-iodine on different mesothelioma cell lines: results of in vitro study. Eur J Cardiothorac Surg (2014) 0.75
HIV evolution: CTL escape mutation and reversion after transmission. Nat Med (2004) 10.21
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol (1993) 8.07
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol (1993) 6.41
The epidemic behavior of the hepatitis C virus. Science (2001) 4.81
Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol (2001) 4.22
Evolutionary aspects of recombination in RNA viruses. J Gen Virol (1999) 3.74
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg (1999) 3.56
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery (1968) 3.56
Extinction rates can be estimated from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1994) 3.47
Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol (1992) 3.37
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg (1991) 2.85
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77
Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology (2002) 2.53
Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol (1994) 2.53
Ecology and evolution of rabies virus in Europe. J Gen Virol (1999) 2.52
Causes of HIV diversity. Nature (1995) 2.48
Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol (1996) 2.25
Inferring population history from molecular phylogenies. Philos Trans R Soc Lond B Biol Sci (1995) 2.21
Regional patterns of soil organic carbon stocks in China. J Environ Manage (2006) 2.21
A likelihood method for the detection of selection and recombination using nucleotide sequences. Mol Biol Evol (1997) 2.20
Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20
Investigation of potential HIV transmission to the patients of an HIV-infected surgeon. JAMA (1993) 2.17
BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg (1974) 2.14
Widespread intra-serotype recombination in natural populations of dengue virus. Proc Natl Acad Sci U S A (1999) 2.12
Networks and groups within the genus Neisseria: analysis of argF, recA, rho, and 16S rRNA sequences from human Neisseria species. Mol Biol Evol (1999) 2.10
The role of MCM proteins in the cell cycle control of genome duplication. Bioessays (1996) 2.09
Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol (1998) 2.07
The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg (1991) 2.06
Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol (2000) 2.06
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol (2010) 2.06
Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol (1995) 2.00
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (1994) 1.95
Parathyroid carcinoma: a collective review. Ann Surg (1969) 1.94
Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics (1999) 1.93
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol (1998) 1.87
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
Predicting antibody hypervariable loop conformation. I. Ensembles of random conformations for ringlike structures. Biopolymers (1987) 1.78
A multigene analysis of the phylogenetic relationships among the flaviviruses (Family: Flaviviridae) and the evolution of vector transmission. Arch Virol (2005) 1.72
Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol (2004) 1.71
Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs. Virus Res (1997) 1.63
Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood (1995) 1.62
Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst (1997) 1.62
Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61
Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference? Cancer (1989) 1.61
Epidemic dynamics revealed in dengue evolution. Mol Biol Evol (2009) 1.58
The molecular evolution of the alcohol dehydrogenase and alcohol dehydrogenase-related genes in the Drosophila melanogaster species subgroup. Mol Biol Evol (1994) 1.58
Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. N Engl J Med (1976) 1.57
Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol (2005) 1.55
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54
The boomerang flap in managing injuries of the dorsum of the distal phalanx. Plast Reconstr Surg (2000) 1.52
Genetic diversity of Borrelia burgdorferi sensu lato in ticks from mainland Portugal. J Clin Microbiol (2000) 1.50
In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol (1994) 1.50
Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol (2001) 1.48
Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr (1995) 1.47
Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. J Gen Virol (1996) 1.46
Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patients. Cancer J (2001) 1.46
A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J Virol (1996) 1.44
Population dynamics of HIV-1 inferred from gene sequences. Genetics (1999) 1.43
Endoscopically-assisted adipofascial flap harvest for soft tissue defects of the lower leg. Br J Plast Surg (1998) 1.42
A phylogenetic survey of recombination frequency in plant RNA viruses. Arch Virol (2005) 1.39
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res (2000) 1.38
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37
The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol (1992) 1.35
Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene (1995) 1.34
Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr (1994) 1.34
Genetic analysis of Israel acute paralysis virus: distinct clusters are circulating in the United States. J Virol (2008) 1.34
Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control (1991) 1.34
Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol (2001) 1.32
Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer. Cancer (1988) 1.32
Evidence for the non-quasispecies evolution of RNA viruses [corrected]. Mol Biol Evol (2001) 1.31
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br J Cancer (2006) 1.29
Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma. N Engl J Med (2001) 1.29
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol (1997) 1.28
Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg (2000) 1.28
The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect (2006) 1.27
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol (2001) 1.26
Immune and artificial selection in the haemagglutinin (H) glycoprotein of measles virus. J Gen Virol (2001) 1.26
Role of NBCe1 and AE2 in secretory ameloblasts. J Dent Res (2008) 1.25
Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. J Hepatol (2001) 1.25
Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res (1995) 1.24
Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol (1993) 1.24
Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst (1993) 1.23
Cellular uptake of amelogenin, and its localization to CD63, and Lamp1-positive vesicles. Cell Mol Life Sci (2007) 1.23
Primer Master: a new program for the design and analysis of PCR primers. Comput Appl Biosci (1996) 1.23
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol (1999) 1.22
Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res (1999) 1.22
New inferences from tree shape: numbers of missing taxa and population growth rates. Syst Biol (2002) 1.22
Pulmonary resection for metastatic sarcoma. Am J Surg (1980) 1.22
Intracranial dural arteriovenous fistulas with or without cerebral sinus thrombosis: analysis of 69 patients. J Neurol Neurosurg Psychiatry (2004) 1.21
Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics (2006) 1.20
The physical activity transition among adults in China: 1991-2011. Obes Rev (2014) 1.20